Follicular Lymphoma
This article looks at the survival rate for Follicular lymphoma
Follicular lymphoma is classified as a Non-Hodgkin's Lymphoma. It
The Food and Drug Administration has approved Gazyva plus bendamustine for the treatment
Biopharmaceutical company Immunomedics announced that the combination of epratuzumab and
FDA Approves Zevalin® Expanded Label as Part of First-Line Therapy in Treatment of Follicular
Autologous stem cell transplantation is linked to better survival outcomes in patients
Spectrum Pharmaceuticals is announcing that positive long-term clinical data for the
Celgene International presented data this weekend at the American Society of Clinical Oncology's
Pennsylvania State Senator Mike Folmer (R-Lebanon) has announced that he has been
In a coup for Roche and a victory for follicular lymphoma patients in the United Kingdom,
Results of a systematic review and meta-analysis of randomized control trials ranging from 1947
Hoping to inch towards a consensus on the best treatment approach or a standard of care for
In a clinical trial of patients with follicular lymphoma
According to two new studies published online August 1 in the Journal of Clinical Oncology,